What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Stay well-hydrated and ensure adequate micronutrient intake, particularly vitamin C, zinc, and copper for collagen formation
This combination helps maintain balanced blood glucose and supports weight control
Meta-analysis reveals reproducible gut microbiome alterations in response to a high-fat diet (in Eng)
By mimicking amylin and enhancing satiety, this weekly injectable peptide empowers patients to eat less, feel full longer, and achieve real body composition changes
Clear instructions on how and how long to store reagents used in the BACTcontrol bacteria analyzer are given in the user manual